Noble Capital Markets research on Helius Medical Technologies is published under ticker symbols HSDT and HSM:CA. The price target is in USD and based on ticker symbol HSDT.
Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNSTM). For more information, visit www.heliusmedical.com.
